CRISPR-based platforms such as SHERLOCK and DETECTR enable point-of-care testing, multiplexed detection, and portable diagnostics, transforming healthcare delivery in resource-limited settings.

This test is ... is a Houston-based molecular diagnostic solutions provider founded in July 2022. The mission is to advance disease detection and treatment by commercializing the CRISPR detection ...

“The FDA’s recognition of IntelliGenome’s CRISPR-TB Blood Test as a Breakthrough Device is a testament to the transformative potential of CRISPR-based diagnostics. It’s rewarding to see innovative ...

This test is the first qualitative real-time polymerase chain reaction (PCR) assay to combine CRISPR technology, designed to detect Mycobacterium tuberculosis (Mtb) cell-free DNA in human serum ...